Results 221 to 230 of about 80,877 (282)

Reversal, Risk, and Responsibility in the Era of Potent Opioids and Overdose. [PDF]

Anesthesiology
Rathmell JP, Kern SE.
europepmc   +1 more source

Reframing Buprenorphine as a Pharmacologic Modifier of Opioid-Induced Respiratory Depression in the Fentanyl Era. [PDF]

Pharmaceuticals (Basel)
Bahji A, Ghauri I, Mathew N, Day N, Tanguay R.   +4 more
europepmc   +1 more source

2025 Korean Guidelines for Cardiopulmonary Resuscitation: Part 5. Cardiac arrest in special circumstances. [PDF]

Clin Exp Emerg Med
Kim TY, Ahn GJ, Cha KC, Kim DH, Sohn Y, Song Y, Shim G, Kim DK, Oh Y, Wi J, Youn CS, Lee ML, Lee MJ, Lee BK, Lee BH, Lee J, Lee CH, Lee H, Jang Y, Jang YS, Jung YH, Jung WJ, Chung SP, Cho GC, Heo JS, Hwang SO.   +25 more
europepmc   +1 more source

Take home naloxone reports. [PDF]

core  

Some of the next articles are maybe not open access.

Related searches:

The naloxone delivery cascade: Identifying disparities in access to naloxone among people who inject drugs in Los Angeles and San Francisco, CA

Drug and Alcohol Dependence, 2021
BACKGROUND Opioid overdoses are a leading cause of injury death in the United States. Providing people who inject drugs (PWID) with naloxone is essential to preventing deaths. However, research regarding gaps in naloxone delivery is limited. METHODS We
Barrot Lambdin, Lynn Wenger, Alex H Kral   +2 more
exaly   +2 more sources

Naloxone [PDF]

Reactions Weekly, 2023
core   +4 more sources

Naloxone

Reactions Weekly, 2021
semanticscholar   +3 more sources